Literature DB >> 6896715

Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol.

M Hallman, R Spragg, J H Harrell, K M Moser, L Gluck.   

Abstract

Autopsy findings suggest that lung surfactant is damaged in the adult respiratory distress syndrome. In the present study 225 bronchoalveolar lavage specimens (78 from 36 patients, 1-78 yr old with respiratory failure, 135 from another 128 patients with other respiratory disease, and 12 from healthy controls) were assayed for the lung profile [lecithin/sphingomyelin (L/S) ratio, saturated lecithin, phosphatidylinositol, and phosphatidylglycerol]. Bronchoalveolar lavage fluid was further analyzed for phospholipids and for phosphatidic acid phosphohydrolase, phospholipase A2, and phosphatidylinositol phosphodiesterase activities. A lipid-protein complex was isolated and analyzed for surface activity, and plasma was measured for myoinositol. There were only small differences seen in the recovery of total phospholipid between respiratory failure patients and normal controls. However, in respiratory failure, phospholipids in bronchoalveolar lavage were qualitatively different from those recovered either from normal controls or from patients with other lung disease: the LO/S ratio, phosphatidylglycerol, and disaturated lecithin were low, whereas sphingomyelin and phosphatidylserine were prominent. These abnormalities were present early in respiratory failure and tended to normalize during recovery. Low L/S ratio (less than 2), and low phosphatidylglycerol (1% or less of glycerophospholipids) in bronchoalveolar lavage was always associated with respiratory failure. Abnormal lavage phospholipids were not due to plasma contamination. The phospholipase studies revealed little evidence of increased catabolism of phospholipids. In respiratory failure, the lipid-protein complexes from lung lavage were not surface active, whereas that from healthy controls had surface properties similar to lung surfactant. Phospholipids from patients with respiratory failure were similar to those from respiratory distress syndrome in the newborn. However, the latter condition is characterized by fast recovery of surfactant deficiency and by high plasma myoinositol that suppresses the synthesis of surfactant phosphatidylglycerol and increases phosphatidylinositol (Pediatr. Res. 1981. 15: 720). On the other hand, in adult respiratory distress syndrome, the abnormality in surfactant phospholipids may last for weeks and in most cases is associated with low phosphatidylinositol, low phosphatidylglycerol, and low plasma myoinositol.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6896715      PMCID: PMC370271          DOI: 10.1172/jci110662

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Isolation of disaturated phosphatidylcholine with osmium tetroxide.

Authors:  R J Mason; J Nellenbogen; J A Clements
Journal:  J Lipid Res       Date:  1976-05       Impact factor: 5.922

Review 2.  The interpretation and significance of the lecithin-sphingomyelin ratio in amniotic fluid.

Authors:  L Gluck; M V Kulovich; R C Borer; W N Keidel
Journal:  Am J Obstet Gynecol       Date:  1974-09       Impact factor: 8.661

Review 3.  "State of the art" review. Pathogenesis of pulmonary edema.

Authors:  N C Staub
Journal:  Am Rev Respir Dis       Date:  1974-03

4.  The chromatographic separation of phospholipids on alumina with solvents containing ammonium salts.

Authors:  M G Luthra; A Sheltawy
Journal:  Biochem J       Date:  1972-01       Impact factor: 3.857

5.  The role of the central nervous system in shock: the centroneurogenic etiology of the respiratory distress syndrome.

Authors:  G Moss
Journal:  Crit Care Med       Date:  1974-07       Impact factor: 7.598

6.  The adult respiratory distress syndrome. Clinical features, factors influencing prognosis and principles of management.

Authors:  T L Petty; D G Ashbaugh
Journal:  Chest       Date:  1971-09       Impact factor: 9.410

7.  Diagnosis of the respiratory distress syndrome by amniocentesis.

Authors:  L Gluck; M V Kulovich; R C Borer; P H Brenner; G G Anderson; W N Spellacy
Journal:  Am J Obstet Gynecol       Date:  1971-02-01       Impact factor: 8.661

Review 8.  The surfactant system of the lung.

Authors:  R J King
Journal:  Fed Proc       Date:  1974-11

9.  Biochemical development of surface activity in mammalian lung. IV. Pulmonary lecithin synthesis in the human fetus and newborn and etiology of the respiratory distress syndrome.

Authors:  L Gluck; M V Kulovich; A I Eidelman; L Cordero; A F Khazin
Journal:  Pediatr Res       Date:  1972-02       Impact factor: 3.756

10.  Phosphatidylglycerol in lung surfactant. III. Possible modifier of surfactant function.

Authors:  M Hallman; L Gluck
Journal:  J Lipid Res       Date:  1976-05       Impact factor: 5.922

View more
  97 in total

Review 1.  The pulmonary physician and critical care. 2. The injured lung: conventional and novel respiratory therapy.

Authors:  A Swami; B F Keogh
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

Review 2.  The pulmonary physician and critical care. 3. Pharmacotherapy in lung injury.

Authors:  M Messent; M J Griffiths
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

Review 3.  Bronchopulmonary dysplasia: early diagnosis, prophylaxis, and treatment.

Authors:  A Greenough
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

Review 4.  The adult respiratory distress syndrome.

Authors:  N F Voelkel
Journal:  Klin Wochenschr       Date:  1989-06-01

Review 5.  Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome.

Authors:  T A Merritt; M Hallman; R Spragg; G P Heldt; N Gilliard
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

Review 6.  The adult respiratory distress syndrome. New insights into diagnosis, pathophysiology, and treatment.

Authors:  M A Matthay
Journal:  West J Med       Date:  1989-02

Review 7.  Ventilation and secretion of pulmonary surfactant.

Authors:  H Wirtz; M Schmidt
Journal:  Clin Investig       Date:  1992-01

8.  Surfactant protein-B polymorphisms and mortality in the acute respiratory distress syndrome.

Authors:  Paul F Currier; Michelle N Gong; Rihong Zhai; Lucille J Pothier; Paul D Boyce; Lilian Xu; Chu-Ling Yu; B Taylor Thompson; David C Christiani
Journal:  Crit Care Med       Date:  2008-09       Impact factor: 7.598

Review 9.  Prevention and therapy of the adult respiratory distress syndrome.

Authors:  B Temmesfeld-Wollbrück; D Walmrath; F Grimminger; W Seeger
Journal:  Lung       Date:  1995       Impact factor: 2.584

10.  Exposure of the hydrophobic components of porcine lung surfactant to oxidant stress alters surface tension properties.

Authors:  N Gilliard; G P Heldt; J Loredo; H Gasser; H Redl; T A Merritt; R G Spragg
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.